Advertisement

Topics

Gambro Company Profile

05:22 EDT 17th October 2017 | BioPortfolio

Ultrafiltration is an extracorporeal treatment in which water, salt, and other blood constituents are removed by a filter. Ultrafiltration was first prescribed as a therapy for diuretic resistant patients more than 35 years ago and numerous subsequent studies have demonstrated clinical benefits in such patients.


News Articles [1 Associated News Articles listed on BioPortfolio]

Global Dialysis Water Treatment Market Research Report 20112023 [Report Updated: 21072017] Prices from USD $3130

SummaryDialysis water treatment system is a kind of highquality, reliable water systems in the field of water systems for dialysis. The water quality meets ANSI/AAMI/ISO and domestic standards for hem...

PubMed Articles [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer

The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis

Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

The purpose of this study is to collect information on the ease of use and thrombogenicity of the Polyflux HD-C4 Big and Fresenius Optiflux 180NR or 200NR dialyzers under conditions of rou...

Prismaflex HF20 Set and Prismaflex® System 7.10 for Acute CRRT in Children

The primary objective of this study is to evaluate the efficacy of the Gambro Prismaflex® HF20 Set based on testing the hypothesis that it delivers sufficient renal replacement therapy to...

European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy

Hypothesis: Free light chain removal haemodialysis will increase the rate of renal recovery in patients with cast nephropathy, severe renal failure and de novo multiple myeloma. This stud...

Companies [4 Associated Companies listed on BioPortfolio]

Gambro BCT, Inc

Gambro BCT is an international company with operations in over 50 countries across the globe. Wherever we are, our commitment to building partnerships and better patient outcomes is unwavering

Gambro Inc.

Gambro’s business concept is to develop, manufacture, market and provide products and services within the areas of dialysis, intensive care, blood bank technology and therapeutics. Gambro is dedica...

Gambro

Ultrafiltration is an extracorporeal treatment in which water, salt, and other blood constituents are removed by a filter. Ultrafiltration was first prescribed as a therapy for diuretic resistant pati...

Gambro Renal Care Product Inc

HOSPAL was founded in 1977 by the merger of the artificial kidney operations of two European chemical and pharmaceutical companies, Rhône-Poulenc and Sandoz. Both companies had been active in this ra...

More Information about "Gambro" on BioPortfolio

We have published hundreds of Gambro news stories on BioPortfolio along with dozens of Gambro Clinical Trials and PubMed Articles about Gambro for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gambro Companies in our database. You can also find out about relevant Gambro Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record